Letrozole Tablet, Film Coated
Product Images NDC 68071-2167

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 68071-2167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2167 4)

This is a medication label for Letrozole 2.5mg tablets from uCare Pharmaceuticals. It includes information such as the lot number, expiration date, NDC numbers, and details about the tablets. It also provides a warning to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F. Additionally, there is a reminder to consult a doctor for medical advice and to report any side effects to the FDA.*

FDA Label Image

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Fig1)

FDA Label Image

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Fig2)

FDA Label Image

Figure 3 Survival By Randomized Treatment Arm (Letrozole Fig3)

FDA Label Image

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Fig4)

Not available.*

FDA Label Image

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Fig5)

This text provides information about the time to progression in days for a treatment group using Letrozole tablets of 0.5mg and 2.5mg. It indicates different time points for progression with varying doses of Letrozole.*

FDA Label Image

Letrozole Structural Formula (Letrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.